Saturday, 16 May 2020

Itolizumab use for Covid-19 encouraging, says Biocon

Biocon has got permission from the Drug Controller General of India to use Itolizumab in moderate to severe patients with Covid-19 complications
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)